Hematology NewsFDA issues public health warning recommending against cesium salt usageFebruary 5, 2020Patient & Survivor Care
Oncology PracticeFDA approves first treatment for advanced epithelioid sarcomaJanuary 24, 2020Sarcoma & GISTRare Diseases
FDA committee rejects oxycodegol, new opioid designed for less abuseJanuary 14, 2020Patient & Survivor Care
Oncology PracticeFDA approves avapritinib for adults with GIST with PDGFRA mutationJanuary 10, 2020GastroenterologyGI OncologySarcoma & GISTGastrointestinal Cancer
Oncology PracticeFDA approves pembrolizumab for BCG-unresponsive NMIBC with CISJanuary 8, 2020Genitourinary Cancer
Oncology PracticeFDA approves antibody-drug conjugate for advanced urothelial cancerDecember 19, 2019Genitourinary Cancer
Hematology NewsFDA approves acalabrutinib for CLL, SLL treatmentNovember 21, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsFDA approves Givlaari for treatment of acute hepatic porphyriaNovember 21, 2019AnemiaRare Diseases
Hematology NewsFDA approves Brukinsa for relapsed, refractory MCLNovember 15, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves anemia treatment for transfusion-dependent beta thalassemia patientsNovember 8, 2019AnemiaTransfusion Medicine
Oncology PracticeLung cancer on the decline, but still higher among men than womenNovember 8, 2019Lung Cancer
Hematology NewsFDA approves Ziextenzo for neutropenia-related infection reductionNovember 5, 2019Patient & Survivor Care
Oncology PracticePresident to nominate oncologist to lead FDANovember 4, 2019Practice ManagementBusiness of Medicine
